Jun 10, 2013
Contact: Vicki Cohn, Mary Ann Liebert, Inc., publishers (914) 740-2100, vcohn@liebertpub.com GPI, Mary Ann Liebert, Inc., and GEN Announce World Stem Cell Summit Collaboration New Rochelle, NY—The Genetics Policy Institute (GPI) and Mary Ann Liebert,...
Jun 06, 2013
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
May 29, 2013
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
May 23, 2013
Contact: Vicki Cohn, Mary Ann Liebert, Inc., (914) 740-2100, ext.
May 13, 2013
MOOCs FORUM, a new journal, is the only publication dedicated exclusively to the development, design, and deployment of the game-changing Massive Open Online Courses (MOOCs).
May 03, 2013
Tumor repressor genes, which inhibit tumor formation, can be "turned off" due to undesirable molecular changes affecting the chromosomes on which the genes reside.
May 03, 2013
Congestive heart failure affects more than 5.3 million Americans, is increasing in prevalence, and is ultimately fatal, but the duration and quality of life leading up to death can be unpredictable and vary greatly.
Apr 24, 2013
New biobased chemicals and materials, and consumer products derived from renewable resources have a smaller carbon footprint and environmental impact than their petroleum-based alternatives.
Apr 10, 2013
New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge.
Apr 10, 2013
One of the main obstacles that stands in the way of using human hematopoietic stem cells (hHSCs) to treat a variety of diseases is the difficulty growing them in culture—they quickly die or differentiate into other cell types.